Home/Filings/4/0001104659-20-010828
4//SEC Filing

Dexcel Pharma Technologies Ltd. 4

Accession 0001104659-20-010828

CIK 0001638381other

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 6:41 PM ET

Size

10.7 KB

Accession

0001104659-20-010828

Insider Transaction Report

Form 4
Period: 2020-01-31
Transactions
  • Sale

    Ordinary Shares

    2020-01-31$0.31/sh725,951$224,3194,424,897 total
  • Sale

    Ordinary Shares

    2020-02-03$0.32/sh80,000$25,4404,344,897 total
  • Sale

    Ordinary Shares

    2020-02-04$0.29/sh110,000$31,9004,234,897 total
Oren Dan
10% Owner
Transactions
  • Sale

    Ordinary Shares

    2020-02-04$0.29/sh110,000$31,9004,234,897 total
  • Sale

    Ordinary Shares

    2020-01-31$0.31/sh725,951$224,3194,424,897 total
  • Sale

    Ordinary Shares

    2020-02-03$0.32/sh80,000$25,4404,344,897 total
Footnotes (5)
  • [F1]Dexcel Pharma Technologies Ltd ("DPT") and Dan Oren, DPT's Executive Chairman, are filing this Form 4 because they have beneficial ownership over ordinary shares of Intec Pharma Ltd. The Ordinary Shares are directly owned by DPT. Mr. Oren is ultimately the sole shareholder of DPT.
  • [F2]The price reported in Column 4 is the weighted average price. The Ordinary Shares were sold in multiple transactions at prices ranging from $0.300 to $0.325, inclusive.
  • [F3]The price reported in Column 4 is the weighted average price. The Ordinary Shares were sold in multiple transactions at prices ranging from $0.300 to $0.324, inclusive.
  • [F4]The price reported in Column 4 is the weighted average price. The Ordinary Shares were sold in multiple transactions at prices ranging from $0.290 to $0.294, inclusive.
  • [F5]The Reporting Persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Issuer

Intec Pharma Ltd.

CIK 0001638381

Entity typeother
IncorporatedIsrael

Related Parties

1
  • filerCIK 0001720007

Filing Metadata

Form type
4
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 6:41 PM ET
Size
10.7 KB